MR-only radiotherapy
Our innovative MRCAT (MR for Calculating ATtenuation) clinical applications lets you plan radiation therapy using MRI as primary imaging modality. Within just one, fast MR exam, MRCAT provides both excellent soft-tissue contrast for target and OAR delineation and CT-like density information for dose calculations. This not only extends the benefits of MRI’s excellent soft-tissue contrast to radiotherapy planning, but it also eliminates arduous, error-prone CT-MRI registration from the process, reducing uncertainties and complexity.